Improved sperm diagnostic test may pinpoint best fertility treatment for couples

Improved sperm diagnostic test may pinpoint best fertility treatment for couples

Improved sperm diagnostic test may pinpoint best fertility treatment for couples

Researchers have developed the first diagnostic test for sperm RNA based on next-generation sequencing. For couples with unexplained infertility, the test may help determine the best infertility treatment for couples having difficulty conceiving.

The research, published in Science Translational Medicine details how male factors could be the cause of infertility in couples even when tested semen parameters are normal. The use of next-generation sequencing of spermatozoal ribonucleic acids, or RNAs, can provide an objective measure of the paternal contribution, and may help guide couples to the most effective method in overcoming infertility.

“Upon validation, this discovery may help to identify those couples who may benefit from assisted reproductive technologies and those couples who may be successful with minimal intervention,” said Stephen Krawetz, professor of molecular medicine and genetics at Wayne State University. “It is our goal to use this technology to reduce both the time to live birth of a healthy child and the cost when couples seek infertility treatment, so as to reduce the stress on the couple. It is our hope that by identifying the extent of the father’s contribution, the responsibility for setting the course for the birth of a healthy child can now be more equally shared.”

The findings herald the possibility of dramatic changes in the way infertile couples are treated and assisted in achieving pregnancy. About 13 per cent of couples of reproductive age experience fertility problems, and while the American Society for Reproductive Medicine estimates that male and female factors contribute about equally to infertility, extensive evaluation of the female partner is traditional before undergoing fertility treatments. Evaluation of the male partner is not as extensive, and is generally relegated to a review of reproductive history, family history and semen analysis considering parameters that include sperm concentration, motility and morphology. The semen parameters evaluation may be useful in the diagnosis of obvious cases of male infertility, said Krawetz, but no single parameter or set of parameters serve as highly predictive of male fertility. Results of those tests are limited in helping select the least invasive fertility treatment for couples having difficulty conceiving.

The diagnostic potential of next-generation sequencing of spermatozoal RNA indicates this method is “better suited to the task” of analysing the male’s role in infertility, and is a step toward personalised precision reproductive medicine that may help guide the couple to their successful treatment, said Krawetz.

The next step is to expand to a prospective blinded study and to begin to define a set of markers that may be predictive of assisted reproduction outcomes.

Improved sperm diagnostic test may pinpoint best fertility treatment for couples

Jodar, M., Sendler, E., Moskovtsev, S.I., et al. (2015) Absence of sperm RNA elements correlates with idiopathic male infertility. Science Translational Medicine 7(295), 295. doi: 10.1126/scitranslmed.aab1287

Source: Newswise

Categories: NEWS